Details of the Drug
General Information of Drug (ID: DMT17H0)
| Drug Name |
Alpha-Homonojirimycin
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
alpha-Homonojirimycin; Homonojirimycin; 119557-99-2; a-Homonojirimycin; alpha-Homoallonojirimycin; (2r,3r,5s,6r)-2,6-bis(hydroxymethyl)piperidine-3,4,5-triol; CHEMBL501355; CHEMBL2111688; Hnj cpd; .alpha.-Homonojirimycin; 2,6-Bis-hydroxymethyl-piperidine-3,4,5-triol; AC1Q59RO; AC1L4LY0; 3,4,5-Piperidinetriol,2,6-bis(hydroxymethyl)-, (2R,3R,5S,6R)-; SCHEMBL2265531; SCHEMBL1469250; SCHEMBL2265529; BDBM18366; CTK4B1372; CLVUFWXGNIFGNC-OVHBTUCOSA-N; CLVUFWXGNIFGNC-QTSLKERKSA-N; alpha-homonojirimycin (alpha-HNJ); BDBM50259956
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 193.2 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -2.4 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 6 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 6 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


